Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 22,814	$ 23,897
General and administrative	7,071	6,974
Total operating expenses	29,885	30,871
Loss from operations	(29,885)	(30,871)
Interest income	1,683	2,918
Interest expense	0	(2)
Other expense, net	(12)	(61)
Loss before income tax provision	(28,214)	(28,016)
Income tax provision	0	0
Segment net loss	$ (28,214)	$ (28,016)
Net loss per share, basic	$ (0.31)	$ (0.35)
Net loss per share, diluted	$ (0.31)	$ (0.35)
Weighted-average common shares used in computing net loss per share, diluted	91,071,436	79,071,652
Weighted-average common shares used in computing net loss per share, basic	91,071,436	79,071,652
Other comprehensive income
Unrealized gain on treasury securities, net of tax	$ (25)	$ 0
Total other comprehensive income	(25)	0
Comprehensive loss	$ (28,239)	$ (28,016)